BCL2 and acute myeloid leukemia: We designed a tiling library targeting BCL2 with Cas9-NG, generated both CBE and ABE versions, and screened in triplicate at high coverage (>10,000 cells per sgRNA) in MOLM13, an AML line sensitive to BCL2 inhibition.